Liz’s Recent Stories
Health Dec 30Are health care claims overblown about artificial intelligence?
Many health industry experts fear AI-based products won’t be able to match the hype.
Health Apr 04Why expensive, unproven stem cell treatments are a new health care trend
Critics suggest the hospitals are exploiting desperate patients and profiting from trendy but unproven treatments.
Health Jun 12Why cancer patients don’t have enough information to make decisions about their treatments
At a time when expensive new cancer treatments are proliferating rapidly, patients have more therapy choices than ever before. Yet they are largely kept in the dark because their doctors either can’t or won’t communicate clearly. Many patients compound the…
Health Jun 03As government-funded cancer research sags, scientists fear U.S. is ‘losing its edge’
Less and less of the research presented at a prominent cancer conference is supported by the National Institutes of Health, a development that some of the country’s top scientists see as a worrisome trend.
Health Jan 10One in three women may receive unnecessary mammograms, study says
The study raises the uncomfortable possibility that some women who believe their lives were saved by mammograms were actually harmed by cancer screenings that led to surgery, radiation and even chemotherapy that they didn’t need.
Health Dec 08Obama vows to sign this sweeping mental health bill Congress passed
The bill strengthens laws mandating parity for mental and physical health care and includes grants to increase the number of psychologists and psychiatrists, who are in short supply across the country.
Health Nov 21Dementia rates decline sharply among senior citizens
A new study finds that the prevalence of dementia has fallen sharply in recent years, most likely as a result of Americans’ rising educational levels and better heart health, which are both closely related to brain health.
Health Sep 20After fierce debate, FDA approves first drug for rare form of muscular dystrophy
The FDA, reacting to lobbying by patients and families, has approved a drug for Duchenne muscular dystrophy, a rare and lethal disease.